SCHEDULE: T. Rowe Price Discloses 11.7% Stake in Shattuck Labs
Beneficial Ownership Disclosure
T. Rowe Price Investment Management, Inc. has reported a significant 11.7% beneficial ownership stake in Shattuck Labs Inc. common stock.
Summary
- T. Rowe Price Investment Management, Inc. reported beneficial ownership of 7,373,891 shares of Shattuck Labs Inc. common stock.
- This represents 11.7% of the total class of securities.
- T. Rowe Price holds sole voting power and sole dispositive power over all 7,373,891 shares.
- The filing indicates the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Shattuck Labs Inc.
- T. Rowe Price is classified as an Investment Adviser (IA).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, as a substantial stake by a respected investment firm like T. Rowe Price can be interpreted as a vote of confidence in Shattuck Labs' future prospects and valuation.
Positives
- A significant stake by a reputable institutional investor like T. Rowe Price can signal confidence in Shattuck Labs' long-term prospects.
- The 11.7% ownership demonstrates a substantial commitment from a major investment firm.
Risks
- The filing explicitly states that the securities were not acquired for the purpose of changing or influencing control, mitigating immediate governance risks from this specific stake.
- As an investment adviser, T. Rowe Price's holdings are subject to market fluctuations and the performance of Shattuck Labs Inc.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that the disclosure of a substantial stake by a prominent asset manager like T. Rowe Price often attracts attention from other institutional investors, potentially validating Shattuck Labs' investment thesis within the broader market. This type of filing is a routine disclosure for large investors crossing certain ownership thresholds.
Stakeholder Impact
- Shareholders: Existing shareholders may view T. Rowe Price's significant stake as a positive indicator, potentially increasing confidence and attracting further investment.
- Management: The company's management might see this as validation of their strategy and operations.
Key Dates
| Date | Description |
|---|---|
| 01/31/2026 | Date of event requiring the filing of this statement. |
| 02/06/2026 | Date the Schedule 13G was signed by T. Rowe Price Investment Management, Inc. |
Recommendation
holdA seasoned investor would likely view T. Rowe Price's 11.7% stake as a positive signal, indicating institutional confidence. However, without additional financial performance data or strategic updates from Shattuck Labs, this filing primarily suggests a "hold" position, encouraging further due diligence into the company's fundamentals before making a more aggressive investment decision.
Keywords
Shattuck Labs Inc., T. Rowe Price Investment Management, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Investment Adviser, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.